Published in Cancer Res on November 01, 1988
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med (2009) 6.61
Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci U S A (1998) 2.58
Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci U S A (1997) 2.19
Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (1997) 1.29
Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum Mol Genet (2008) 1.20
P53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochim Biophys Acta (2008) 1.19
MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice. Mol Cell Biol (2007) 1.15
Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1. Mol Cell Biol (2005) 1.07
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer (1995) 1.06
Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity. Am J Pathol (1993) 1.04
Evidence that retroviral transduction is mediated by DNA not by RNA. Proc Natl Acad Sci U S A (1990) 1.02
MdmX regulates transformation and chromosomal stability in p53-deficient cells. Cell Cycle (2008) 0.95
Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br J Cancer (1994) 0.92
Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients. Br J Cancer (1997) 0.82
High rate of diversification and reversal among subclones of neoplastically transformed NIH 3T3 clones. Proc Natl Acad Sci U S A (1992) 0.80
A retroviral promoter is sufficient to convert proto-src to a transforming gene that is distinct from the src gene of Rous sarcoma virus. Proc Natl Acad Sci U S A (1990) 0.80
Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells. Genome Res (2017) 0.75
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (1993) 5.69
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet (1996) 4.59
Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group. Histopathology (2000) 3.05
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A (2001) 2.91
Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts. Genes Chromosomes Cancer (1999) 2.72
Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A (2000) 2.61
Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol (1996) 2.42
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res (1997) 2.14
Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer (1992) 1.99
Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet (1997) 1.95
LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics (1996) 1.93
Whole-arm t(1;16) and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer (1992) 1.86
Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene (1996) 1.77
Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer (1991) 1.72
Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res (1994) 1.70
Isochromosomes in neoplasia. Genes Chromosomes Cancer (1994) 1.64
A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42. Leukemia (2006) 1.60
Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics (1996) 1.59
Cardiac puncture of fetus with Hurler's disease avoiding abortion of unaffected co-twin. Lancet (1978) 1.52
Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol (1996) 1.48
Multiple unrelated clonal chromosome abnormalities in an in situ squamous cell carcinoma of the skin. Cancer Genet Cytogenet (1988) 1.48
Occupational exposure to petroleum products in men with acute non-lymphocytic leukaemia. Br Med J (1978) 1.47
Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet (1997) 1.46
Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol (2001) 1.44
Trisomy 7 in short-term cultures of colorectal adenocarcinomas. Genes Chromosomes Cancer (1991) 1.41
New chromosomal rearrangement, t(12;22)(p13;q12), in acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1991) 1.39
Abberant cytogenetic evolution pattern of Philadelphia-positive chronic myeloid leukemia treated with interferon-alpha. Leukemia (1996) 1.39
Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer (1999) 1.35
Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer (1992) 1.34
Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet (1989) 1.32
Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer (1993) 1.32
The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum Genet (1999) 1.31
Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas: a report of the CHAMP Study Group. Am J Surg Pathol (1997) 1.30
Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet (1988) 1.30
Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int J Cancer (1995) 1.30
Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer (1998) 1.29
Lipomas have characteristic structural chromosomal rearrangements of 12q13-q14. Int J Cancer (1987) 1.28
Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer (1995) 1.28
Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum Mol Genet (2001) 1.28
Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer (2007) 1.27
Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer (1992) 1.19
Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. Am J Pathol (1999) 1.19
Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol (2000) 1.18
In situ hybridization localizes the human putative oncogene GLI to chromosome subbands 12q13.3-14.1. Hum Genet (1989) 1.18
Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer (1998) 1.18
Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group. Mod Pathol (2000) 1.18
Hibernomas are characterized by rearrangements of chromosome bands 11q13-21. Int J Cancer (1994) 1.17
Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet (1995) 1.17
The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res (1999) 1.16
Chromosome aberrations and metronidazole. Lancet (1976) 1.16
Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res (1994) 1.16
Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group. Mod Pathol (1999) 1.15
Chromosomes and cancer. Hereditas (1977) 1.15
POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol (2008) 1.15
Monosomy and trisomy of 15q24----qter in a family with a translocation t(6;15)(p25;q24). Clin Genet (1987) 1.15
Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer (1995) 1.15
Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features. J Pathol (1997) 1.15
Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer (1993) 1.14
Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology. Genes Chromosomes Cancer (1998) 1.14
Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res (1999) 1.13
Trichorhinophalangeal syndrome type I: symptoms and signs, radiology and genetics. Ann Rheum Dis (1986) 1.13
Clustering of aberrations to specific chromosomes in human neoplasms. II. A survey of 287 neoplasms. Hereditas (1976) 1.13
Loss of chromosome band 8q24 in sporadic osteocartilaginous exostoses. Genes Chromosomes Cancer (1994) 1.13
Karyotypic abnormalities in tumours of the pancreas. Br J Cancer (1993) 1.13
Primary vs. secondary neoplasia-associated chromosomal abnormalities--balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer (1996) 1.13